By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

FORUM Pharmaceuticals (Formerly Known As EnVivo Pharmaceuticals, Inc.) 

480 Arsenal Street
Building 1
Watertown  Massachusetts  02472  U.S.A.
Phone: 617-225-4250 Fax: 617-225-4267


SEARCH JOBS



Segment
Drug Discovery





Company News
FORUM Pharmaceuticals Presents FRM-0334 Studies At 9th International Conference On Frontotemporal Dementias 10/29/2014 8:55:40 AM
FORUM Pharmaceuticals Appoints Christine Boisclair As Vice President, Regulatory Affairs 7/9/2014 11:03:15 AM
FORUM Pharmaceuticals Appoints Todd Shegog As Chief Financial Officer 4/22/2014 7:03:01 AM
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals 4/2/2014 8:46:12 AM
EnVivo Pharmaceuticals, Inc. Initiates COGNITIV AD, A Phase 3 Clinical Trial Program Of Encenicline (EVP-6124) In Alzheimer’s Disease 1/22/2014 9:24:17 AM
Ex-Millennium: The Takeda Oncology Company CEO to Head EnVivo Pharmaceuticals, Inc. 7/11/2013 7:15:42 AM
EnVivo Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Trial Program of EVP-0962 in Alzheimer’s Disease 1/3/2013 9:54:46 AM
EnVivo Pharmaceuticals, Inc. Presents Additional EVP-6124 Phase 2b Clinical Trial Results at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting 10/31/2012 7:51:10 AM
EnVivo Pharmaceuticals, Inc.' Drug Helps Memory in Early Study 7/18/2012 10:20:41 AM
EnVivo Pharmaceuticals, Inc. to Present Phase 2b Clinical Data of Lead Program in Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2012 6/13/2012 10:38:51 AM
1234
//-->